Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Shares Outstanding (Weighted Average): 2014-2024

Historic Shares Outstanding (Weighted Average) for Protara Therapeutics (TARA) over the last 11 years, with Dec 2024 value amounting to $20.6 million.

  • Protara Therapeutics' Shares Outstanding (Weighted Average) rose 0.21% to $412,113 in Q4 2015 from the same period last year, while for Sep 2015 it was $411,468, marking a year-over-year increase of 0.06%. This contributed to the annual value of $20.6 million for FY2024, which is 81.52% up from last year.
  • As of FY2024, Protara Therapeutics' Shares Outstanding (Weighted Average) stood at $20.6 million, which was up 81.52% from $11.4 million recorded in FY2023.
  • In the past 5 years, Protara Therapeutics' Shares Outstanding (Weighted Average) registered a high of $20.6 million during FY2024, and its lowest value of $11.2 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $14.4 million, with a median of $11.4 million in 2023.
  • Data for Protara Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 2,189.84% (in 2020) over the last 5 years.
  • Protara Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $11.2 million in 2020, then climbed by 0.21% to $11.2 million in 2021, then increased by 0.28% to $11.3 million in 2022, then grew by 0.87% to $11.4 million in 2023, then skyrocketed by 81.52% to $20.6 million in 2024.